Skip to content

Evaluation of Brassica oleracea and Zingiber officinale Gel in Frozen Shoulder

Formulation and Evaluation of Brassica oleracea and Zingiber officinale Gel in Frozen Shoulder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220615055179N5
Enrollment
375
Registered
2025-01-03
Start date
2025-01-12
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive capsulitis of shoulder. Adhesive capsulitis of shoulder

Interventions

Sponsors

Muhammad Nawaz Sharif University of Agriculture
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Participants diagnosed with frozen shoulder and stiff frozen shoulder Limited shoulder joint range of motion Participants who have experienced pain (NPRS > 4) during movement Age (30- 60 y) Symptom duration > 3 months

Exclusion criteria

Exclusion criteria: History of fracture around shoulder Inflammatory disorder around shoulder Any neurological condition Cardiac conditions Acute or chronic conditions affecting joint mobility Surgical release of capsules History of steroidal injection in the affected area Patients with joint infection

Design outcomes

Primary

MeasureTime frame
Shoulder range of motion. Timepoint: Pre (before starting the intervention) and Post evaluation (after every 3rd session of treatment, evaluation will be done). Method of measurement: Goniometry.;Pain. Timepoint: Pre (before starting the intervention) and Post evaluation (daily after each treatment session, evaluation will be done). Method of measurement: Visual Analog Scale (VAS) and Numerical Pain Rating Scale (NPRS).

Secondary

MeasureTime frame
Inflammation. Timepoint: Pre (before starting the intervention) and Post evaluation (after 3-4 weeks when treatment sessions/ intervention will be completed depending on different individuals and conditions or grades of other individuals). Method of measurement: C-reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR).

Countries

Pakistan

Contacts

Public ContactQurat-Ul- Ain

Muhammad Institute of Medical and Allied Sciences

qain0635@gmail.com+92 303 9427506

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026